About Semaglutide
Semaglutide is a synthetic GLP-1 receptor agonist used in metabolic and endocrine research. Supplied as a lyophilized powder for laboratory investigations of incretin receptor pharmacology, glucose-regulatory signaling, and downstream pathway activity in controlled experimental systems. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99(HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Comparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study.
Recent research on Semaglutide: Comparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study.
Read Full Study on PubMedPlain language review: non-invasive screening for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) in primary care.
Recent research on Semaglutide: Plain language review: non-invasive screening for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) in primary care.
Read Full Study on PubMedAdditional Studies
Preferences for Obesity Medications Among People With Overweight or Obesity in the United States: A Discrete-Choice Experiment (OPTIC).
Recent research on Semaglutide: Preferences for Obesity Medications Among People With Overweight or Obesity in the United States: A Discrete-Choice Experiment (OPTIC).
Read on PubMedStructural Overview of GLP-1 Analogs.
Recent research on Semaglutide: Structural Overview of GLP-1 Analogs.
Read on PubMedMetabolic Effects of a GLP-1 Analog Combined with Aerobic Training in Ovariectomized Rats.
Recent research on Semaglutide: Metabolic Effects of a GLP-1 Analog Combined with Aerobic Training in Ovariectomized Rats.
Read on PubMedAssessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization.
Recent research on Semaglutide: Assessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization.
Read on PubMedInternational expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update.
Recent research on Semaglutide: International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update.
Read on PubMedImprovement of small fiber neuropathy assessed by corneal confocal microscopy following semaglutide treatment: a case report and literature review.
Recent research on Semaglutide: Improvement of small fiber neuropathy assessed by corneal confocal microscopy following semaglutide treatment: a case report and literature review.
Read on PubMedRelated Research
Purchase Semaglutide from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.